1. Home
  2. STVN vs RYAN Comparison

STVN vs RYAN Comparison

Compare STVN & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • RYAN
  • Stock Information
  • Founded
  • STVN 1949
  • RYAN 2010
  • Country
  • STVN Italy
  • RYAN United States
  • Employees
  • STVN N/A
  • RYAN N/A
  • Industry
  • STVN Containers/Packaging
  • RYAN Specialty Insurers
  • Sector
  • STVN Consumer Discretionary
  • RYAN Finance
  • Exchange
  • STVN Nasdaq
  • RYAN Nasdaq
  • Market Cap
  • STVN 6.2B
  • RYAN 7.4B
  • IPO Year
  • STVN 2021
  • RYAN 2021
  • Fundamental
  • Price
  • STVN $22.96
  • RYAN $56.52
  • Analyst Decision
  • STVN Buy
  • RYAN Buy
  • Analyst Count
  • STVN 4
  • RYAN 12
  • Target Price
  • STVN $25.13
  • RYAN $74.80
  • AVG Volume (30 Days)
  • STVN 341.4K
  • RYAN 1.3M
  • Earning Date
  • STVN 08-05-2025
  • RYAN 10-29-2025
  • Dividend Yield
  • STVN 0.27%
  • RYAN 0.85%
  • EPS Growth
  • STVN 6.78
  • RYAN N/A
  • EPS
  • STVN 0.57
  • RYAN N/A
  • Revenue
  • STVN $1,344,798,591.00
  • RYAN $2,754,521,000.00
  • Revenue This Year
  • STVN $8.24
  • RYAN $27.79
  • Revenue Next Year
  • STVN $10.38
  • RYAN $16.67
  • P/E Ratio
  • STVN $40.05
  • RYAN $257.84
  • Revenue Growth
  • STVN 5.28
  • RYAN 23.84
  • 52 Week Low
  • STVN $17.12
  • RYAN $55.77
  • 52 Week High
  • STVN $28.00
  • RYAN $77.16
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • RYAN 32.72
  • Support Level
  • STVN $21.51
  • RYAN $58.41
  • Resistance Level
  • STVN $23.72
  • RYAN $58.32
  • Average True Range (ATR)
  • STVN 0.84
  • RYAN 1.18
  • MACD
  • STVN 0.09
  • RYAN -0.04
  • Stochastic Oscillator
  • STVN 65.77
  • RYAN 4.12

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Share on Social Networks: